Recruiting studies: Meningioma Malignant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
NA · 1 location(s) · Beijing Sanbo Brain Hospital · NCT04501705 SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT05254197 Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Phase 2 · 1 location(s) · Mayo Clinic · NCT04082520 Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
NA · 1 location(s) · University of California, San Francisco · NCT06557512 NK Cell Therapy for Malignant Solid Brain Tumors
NA · 4 location(s) · Peking University Third Hospital · NCT07552233 TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06640582 Predictive Factors for Survival in Aggressive Meningiomas
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05793034 Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
NA · 1 location(s) · Emory University · NCT04278118 Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgi
EARLY_Phase 1 · 1 location(s) · Eben Rosenthal · NCT07493447 SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
NA · 2 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06878469 Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3
Phase 2 · 8 location(s) · Northwestern University · NCT02847559 Regorafenib for Recurrent Meningioma (MIRAGE Trial)
Phase 2 · 17 location(s) · Istituto Oncologico Veneto IRCCS · NCT06275919 Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 · 1 location(s) · Jazz Pharmaceuticals · NCT04541082 A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Phase 2 · 12 location(s) · Exelixis · NCT07428616 Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tu
Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06650163 Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/Phase 2 · 4 location(s) · Nationwide Children's Hospital · NCT05278208 Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Phase 2 · 1 location(s) · Emory University · NCT06132685 Abemaciclib in Newly Diagnosed Meningioma Patients
Phase 2 · 1 location(s) · Nader Sanai · NCT05940493

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.